Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder

Hua Li, Aadi P. Sagar, S. Kéri

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Evidence suggests that microglia-mediated processes are implicated in the pathophysiology of major depressive disorder (MDD). The relationship between these processes and cognitive dysfunctions has not been explored. Methods: We recruited 50 never-medicated patients with MDD and 30 healthy control subjects. We used [18F]-FEPPA positron emission tomography (PET) to examine translocator protein total distribution volume (TSPO VT), a marker of microglia. Cognitive functions were evaluated with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) (attention, immediate and delyed memory, language, and visuospatial functions). Results: Patients with MDD showed elevated TSPO VT in all regions of interest (white matter, grey matter, frontal cortex, temporal cortex, and hippocampus) and were impaired on the attention and delayed memory domains of the RBANS. In the frontal cortex, increased TSPO VT was associated with lower scores on the RBANS attention domain when the analysis was corrected for age, gender, education, and depressive symptoms. Limitations: Affective functions were not investigated, the specificity of [18F]-FEPPA binding is limited, TSPO may reflect microglia/macrophage density rather than activation, and the sample was not balanced (more patients were included than controls). Conclusions: Attentional dysfunctions may be associated with microglial pathology in the frontal cortex of untreated patients with MDD.

Original languageEnglish
Pages (from-to)305-310
Number of pages6
JournalJournal of Affective Disorders
Volume241
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

Major Depressive Disorder
Frontal Lobe
Microglia
Repression (Psychology)
Temporal Lobe
Short-Term Memory
Positron-Emission Tomography
Cognition
Hippocampus
Healthy Volunteers
Language
Macrophages
Depression
Pathology
Education
Cognitive Dysfunction
Proteins
N-(2-((N-(4-phenoxypyridin-3-yl)acetamido)methyl)phenoxy)ethyl fluoride

Keywords

  • Cognition
  • Inflammation
  • Major depression
  • PET
  • Translocator protein

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder. / Li, Hua; Sagar, Aadi P.; Kéri, S.

In: Journal of Affective Disorders, Vol. 241, 01.12.2018, p. 305-310.

Research output: Contribution to journalArticle

@article{d7306f7f8111476b8c6088ae3f1575bf,
title = "Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder",
abstract = "Background: Evidence suggests that microglia-mediated processes are implicated in the pathophysiology of major depressive disorder (MDD). The relationship between these processes and cognitive dysfunctions has not been explored. Methods: We recruited 50 never-medicated patients with MDD and 30 healthy control subjects. We used [18F]-FEPPA positron emission tomography (PET) to examine translocator protein total distribution volume (TSPO VT), a marker of microglia. Cognitive functions were evaluated with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) (attention, immediate and delyed memory, language, and visuospatial functions). Results: Patients with MDD showed elevated TSPO VT in all regions of interest (white matter, grey matter, frontal cortex, temporal cortex, and hippocampus) and were impaired on the attention and delayed memory domains of the RBANS. In the frontal cortex, increased TSPO VT was associated with lower scores on the RBANS attention domain when the analysis was corrected for age, gender, education, and depressive symptoms. Limitations: Affective functions were not investigated, the specificity of [18F]-FEPPA binding is limited, TSPO may reflect microglia/macrophage density rather than activation, and the sample was not balanced (more patients were included than controls). Conclusions: Attentional dysfunctions may be associated with microglial pathology in the frontal cortex of untreated patients with MDD.",
keywords = "Cognition, Inflammation, Major depression, PET, Translocator protein",
author = "Hua Li and Sagar, {Aadi P.} and S. K{\'e}ri",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/j.jad.2018.08.021",
language = "English",
volume = "241",
pages = "305--310",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

TY - JOUR

T1 - Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder

AU - Li, Hua

AU - Sagar, Aadi P.

AU - Kéri, S.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Background: Evidence suggests that microglia-mediated processes are implicated in the pathophysiology of major depressive disorder (MDD). The relationship between these processes and cognitive dysfunctions has not been explored. Methods: We recruited 50 never-medicated patients with MDD and 30 healthy control subjects. We used [18F]-FEPPA positron emission tomography (PET) to examine translocator protein total distribution volume (TSPO VT), a marker of microglia. Cognitive functions were evaluated with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) (attention, immediate and delyed memory, language, and visuospatial functions). Results: Patients with MDD showed elevated TSPO VT in all regions of interest (white matter, grey matter, frontal cortex, temporal cortex, and hippocampus) and were impaired on the attention and delayed memory domains of the RBANS. In the frontal cortex, increased TSPO VT was associated with lower scores on the RBANS attention domain when the analysis was corrected for age, gender, education, and depressive symptoms. Limitations: Affective functions were not investigated, the specificity of [18F]-FEPPA binding is limited, TSPO may reflect microglia/macrophage density rather than activation, and the sample was not balanced (more patients were included than controls). Conclusions: Attentional dysfunctions may be associated with microglial pathology in the frontal cortex of untreated patients with MDD.

AB - Background: Evidence suggests that microglia-mediated processes are implicated in the pathophysiology of major depressive disorder (MDD). The relationship between these processes and cognitive dysfunctions has not been explored. Methods: We recruited 50 never-medicated patients with MDD and 30 healthy control subjects. We used [18F]-FEPPA positron emission tomography (PET) to examine translocator protein total distribution volume (TSPO VT), a marker of microglia. Cognitive functions were evaluated with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) (attention, immediate and delyed memory, language, and visuospatial functions). Results: Patients with MDD showed elevated TSPO VT in all regions of interest (white matter, grey matter, frontal cortex, temporal cortex, and hippocampus) and were impaired on the attention and delayed memory domains of the RBANS. In the frontal cortex, increased TSPO VT was associated with lower scores on the RBANS attention domain when the analysis was corrected for age, gender, education, and depressive symptoms. Limitations: Affective functions were not investigated, the specificity of [18F]-FEPPA binding is limited, TSPO may reflect microglia/macrophage density rather than activation, and the sample was not balanced (more patients were included than controls). Conclusions: Attentional dysfunctions may be associated with microglial pathology in the frontal cortex of untreated patients with MDD.

KW - Cognition

KW - Inflammation

KW - Major depression

KW - PET

KW - Translocator protein

UR - http://www.scopus.com/inward/record.url?scp=85051796110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051796110&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2018.08.021

DO - 10.1016/j.jad.2018.08.021

M3 - Article

VL - 241

SP - 305

EP - 310

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -